| Variables |
|
OS |
|
Univarite
HR(95% CI) |
p |
Multivariate
HR(95% CI) |
p |
LDH
(<246 / ≥246) |
1.31(0.80-2.13) |
0.286 |
- |
- |
Age
(<40 / ≥40) |
0.74(0.38-1.46) |
0.390 |
- |
-
|
Gender
(Male / female) |
1.12(0.69-1.82) |
0.653 |
- |
-
|
ALP(
(<129 / ≥129) |
1.09(0.63-1.89) |
0.755 |
- |
-
|
Creatinin
(<1.3 / ≥1.3) |
0.98(0.24-4.01) |
0.744 |
- |
-
|
Fibrinogen group
(<400 /≥400) |
1.17(0.65-2.10) |
0.601 |
- |
-
|
Donor status
(gender match / gender mismatch) |
1.27(0.77-2.11) |
0.351 |
- |
-
|
Diagnosis
(Acute leukemia / Others) |
0.99(0.52-1.88) |
0.984 |
- |
-
|
Time –to-tx interval (months
(<12months / >12months) |
1.58(0.97-2.56) |
0.06 |
1.85(1.12-3.07) |
0.017 |
HLA match
(full match / ≥1 mismatch) |
1.70(0.90-3.20) |
0.101 |
- |
- |
Conditioning regimen
(Myeloablative Nonmyeloablative) |
1.37(0.82-2.29) |
0.226 |
- |
- |
CD34+ group
(<8 / >8 (106/kg)) |
0.69(0.34-1.39) |
0.297 |
- |
- |
